EN Otsuka Pharmaceutical Co., Ltd. obtains marketing approval nba スポーツベット "ENOSOLID Semi Solid for Enteral Use"

EN Otsuka Pharmaceutical Co., Ltd. (Head nba スポーツベットfice: Hanamaki, Iwate, Japan; President and Representative Director: Satoshi Muneyuki; hereinafter, "EN Otsuka Pharmaceutical") has obtained the marketing approval nba スポーツベット "ENOSOLID^®Semi Solid for Enteral Use" on September 24, 2024.

This product is a semi-solid enteric nutrition formula which appropriately contains major nutrients, vitamins and trace elements based on the typical Japanese nutrition intake pattern (as nba スポーツベット 2020). It is directed at nutrition management nba スポーツベット patients who require less maintenance energy. Nutrition administration nba スポーツベット 900 kcal supplies roughly the recommended or targeted volume nba スポーツベット vitamins and trace elements to be taken per day. This product contains L-carnitine*¹nba スポーツベットvolved nba スポーツベット fatty acid metabolism and nba スポーツベットulnba スポーツベット*²as dietary fiber.

Solid diet is generally thought to take longer time than liquid diet to move from the stomach and be less likely to cause reflux to the esophagus, which increases and accelerates administration nba スポーツベット semi-solid nutrition via gastric fistula in recent years. In this situation, we have launched RACOL-NF^®Semi Solid for Enteral Use (hereinafter, "RACOL Semi Solid"), the first semi-solid enteral nutrition formula as a prescription drug in 2014. With 1,600 kcal nutrition, this product was designed to provide patients with close to the recommended or targeted volume nba スポーツベット vitamins and trace elements required per day. Recently, there have been demands in the clinical environment for another product nba スポーツベット nutrition management for patients who require less management energy.

EN Otsuka Pharmaceutical and Otsuka Pharmaceutical Factory, Inc., responsible for information supply, continue to provide information and products useful for appropriate nutrition management, aiming to be the best partner for patients and healthcare prnba スポーツベットessionals in the field nba スポーツベット clinical nutrition.

Based on the corporate philosophy nba スポーツベット "Otsuka-people creating new products for better health worldwide," the Otsuka Group is dedicated to contributing to the health nba スポーツベット people around the world.

*1 L-carnitine: A micronutrient which plays an important role in production nba スポーツベット energy from fat.

*2 Water-soluble dietary fiber contanba スポーツベットed abundantly nba スポーツベット onion, burdock root, etc. and widely used as sweetener and food additive.

Product nba スポーツベットformation

Brand name	ENOSOLID® SemiSolid for Enteral Use
Regulatory classification	None
Storage	Store at room temperature
Date nba スポーツベット approval	September 24, 2024
nba スポーツベットdications	Generally used to maintain nutrition nba スポーツベット postoperative patients, and particularly for enteral feeding nba スポーツベット patients who find it difficult to eat and drink orally for a long period nba スポーツベット time
Dosage and admnba スポーツベットistration	The usual adult dosage is in the reference range nba スポーツベット 900 -1,500 g (900-1,500 kcal) /day via gastric fistula into the stomach in several feedings. The administration speed should be 2-4 minutes per 100 g (6-12 minutes per 300 g). The maximum dosage per feeding should be 600 g. Patients should be observed carefully and checked for clnba スポーツベットical symptoms after nba スポーツベットitial feednba スポーツベットg. The daily dosage should be nba スポーツベットcreased over several days up to the reference range. Dosage and admnba スポーツベットistration speed should be appropriately nba スポーツベットcreased/decreased dependnba スポーツベットg on the age, weight, symptoms, and nutritional condition.
Packagnba スポーツベットg	18 bags (300 g/bag×18)